56663-76-4 Usage
Uses
Used in Pharmaceutical Industry:
2,2-Dimethyl-but-3-ynoic acid is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drug molecules. Its unique structure allows for the creation of complex organic compounds that can target specific biological pathways, potentially leading to the discovery of novel therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 2,2-dimethyl-but-3-ynoic acid is utilized as a key building block for constructing a variety of organic compounds. Its reactivity and structural features make it a valuable component in the synthesis of complex organic molecules, which can be applied in various chemical and industrial processes.
Used in Research Laboratories:
2,2-Dimethyl-but-3-ynoic acid is employed as a research chemical in laboratories, where it serves as a fundamental component in the exploration of new synthetic pathways and the development of innovative chemical reactions. Its use in research aids in expanding the understanding of organic chemistry and contributes to the advancement of scientific knowledge in related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 56663-76-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,6,6 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 56663-76:
(7*5)+(6*6)+(5*6)+(4*6)+(3*3)+(2*7)+(1*6)=154
154 % 10 = 4
So 56663-76-4 is a valid CAS Registry Number.
56663-76-4Relevant academic research and scientific papers
KINASE INHIBITORS
-
, (2014/03/25)
There are provided compounds of formula (I), (Formula (I)) wherein R1 to R5, X1, X2, Ar, L, E, A, A1, G and G1 have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.
Cobalt-catalyzed carboxylation of propargyl acetates with carbon dioxide
Nogi, Keisuke,Fujihara, Tetsuaki,Terao, Jun,Tsuji, Yasushi
, p. 13052 - 13055 (2015/02/19)
The cobalt-catalyzed carboxylation of propargyl acetates with CO2 (1 atm) is described. The reaction proceeds at room temperature in the presence of Mn powder as a reducing reagent. Various propargyl acetates are converted to the corresponding carboxylic acids in good to high yields.
